Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29561223 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL29134150 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL29285335 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL6131301 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL8392925 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL4069557 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL10396024 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL8374876 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL9436900 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL28044723 | 1.00 | DNM1 (0.61) | DNM1TSHRTHRBCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428042-B2 | Compound useful for manufacturing salacinol, method for manufacturing the compound, method for manufacturing salacinol, methods for protecting and deprotecting diol group, and protective agent for diol group | FUJIFILM CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20180327378-A1 | COMPOUND USEFUL FOR MANUFACTURING SALACINOL, METHOD FOR MANUFACTURING THE COMPOUND, METHOD FOR MANUFACTURING SALACINOL, METHODS FOR PROTECTING AND DEPROTECTING DIOL GROUP, AND PROTECTIVE AGENT FOR DIOL GROUP | FUJIFILM CORPORATION (JP) | 2018-11-15 | — | — | US | disclosed |
| EP-1146067-A1 | PROCESS AND APPARATUS FOR CONTINUOUS PRODUCTION OF CROSSLINKED POLYMER | Mitsui Chemicals, Inc. (JP) | 2001-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428042-B2 | Compound useful for manufacturing salacinol, method for manufacturing the compound, method for manufacturing salacinol, methods for protecting and deprotecting diol group, and protective agent for diol group | SPTSSB, DHCR7, ADH1A | DNM1 1185/4885TSHR 1978/4885THRB 399/4885 |
| US-20180327378-A1 | COMPOUND USEFUL FOR MANUFACTURING SALACINOL, METHOD FOR MANUFACTURING THE COMPOUND, METHOD FOR MANUFACTURING SALACINOL, METHODS FOR PROTECTING AND DEPROTECTING DIOL GROUP, AND PROTECTIVE AGENT FOR DIOL GROUP | SPTSSB, DHCR7, ADH1A | DNM1 1185/4885TSHR 1978/4885THRB 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.